|
S.N. Tolpygina
Possibility of high-selective adrenoblockers use in combined therapy ofpatients with metabolic syndrome
|
№4 / 2018
|
|
L.A. Andreeva, L.A. Panchenkova, A.I. Martynov, E.A. Troshina, K.A. Khamidova, E.E. Kazanceva, L.A. Medvedeva, G.G. Karnuta, T.E. Yurkova
Dayly dynamics of indices of central aortic pressure and arterial stiffness in patients with arterial hypertension in the composition of a metabolic syndrome at the background of a fixed-dose combination of perindopril arginine and indapamide
|
№1 / 2018
|
|
O.A. Gromova, A.G. Kalacheva, I.Yu. Torshin, T.R. Grishina, N.I. Tapilskaya
Deficiencies of magnesium and pyridoxine and the pathogenesis of the metabolic syndrome
|
№3 / 2017
|
|
M.V. Gorbunova, S.L. Babak, A.G. Malyavin
Results of applying A-Flex therapy in patients with obstructive sleep apnea and metabolic syndrome
|
№1 / 2017
|
|
I.M. Marusenko, I.I. Polskaya, T.I. Kulagina, N.N. Vezikova
Metabolic syndrome in patients with gout and its impact on the risk of cardiovascular diseases
|
№3 / 2016
|
|
A.V. Budnevsky, B.B. Romashov, N.V. Polyakova, Ye.Yu. Malysh
Actual issues of pathogenesis, clinic and treatment of chronic obstructive pulmonary disease and diabetes
|
№1 / 2016
|
Русский
